INTENT Biologics

Intent is a biotechnology company building a platform for the intentional design of biologics, moving beyond the stochastic nature of traditional drug discovery. By integrating high-throughput experimental data with advanced computational models, the company engineers proteins and antibodies with optimized therapeutic and biophysical properties. Intent's approach aims to create next-generation medicines for complex diseases in immunology and oncology with improved potency and safety profiles. The company is backed by leading life science investors and is led by a team with deep expertise in protein engineering and drug development.